NCLT approves Dhanuka Lab’s Rs 1,116 crore plan to buy debt-hit Orchid Pharma

A consortium of 24 banks has lent a total of over Rs 3,200 crore to the drug maker and the lenders will be taking a haircut of around 65%.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2X5HY60
via IFTTT